Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
A Prospective, Randomized, Controlled, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
Sponsor: RxSight, Inc.
A NA clinical study on Aphakia and Cataract, this trial is completed. The trial is conducted by RxSight, Inc. and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
-
Dec 2021 — Jan 2022 [monthly]
Completed NA
-
May 2021 — Dec 2021 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Jan 2021 — May 2021 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting NA
-
Oct 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2019 — Oct 2019 [monthly]
Recruiting NA
-
Nov 2018 — Jan 2019 [monthly]
Recruiting NA
-
Oct 2018 — Nov 2018 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RxSight, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .